Obesity and other clinical endpoints in steroid-sensitive nephrotic syndrome

Pediatr Nephrol. 2007 Mar;22(3):471; author reply 472-3. doi: 10.1007/s00467-006-0362-5. Epub 2006 Dec 7.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Adult
  • Child
  • Female
  • Glucocorticoids / adverse effects*
  • Glucocorticoids / therapeutic use
  • Humans
  • Male
  • Nephrotic Syndrome / drug therapy*
  • Obesity / chemically induced*
  • Obesity / etiology

Substances

  • Glucocorticoids